“Neonatal Abstinence Syndrome: Breastfeeding as a Supportive Treatment”
Event Navigation
Medela* presents: “Neonatal Abstinence Syndrome: Breastfeeding as a Supportive Treatment”
This presentation provides a brief history on neonatal abstinence syndrome and national data related to incidence. The presenter will talk about the impact this nationwide rising occurrence is having on healthcare providers and hospitals. An in-depth review of the growing body of evidence supporting breast milk and breastfeeding as positive support for improving outcomes for NAS babies will be covered. The session will also explore regulatory recommendations, and briefly discuss national and state programs as solutions to prevent opioid use disorder in pregnancy.
Learning Objectives
- Describe evidence-based practice recommendations to improve infant outcomes for opioid-exposed infants
- Identify the benefits of breastfeeding for mother and infant
- Identify national and state organizations with programs to prevent and improve incidence
Presenter:
Patrice Hatcher, MBA, BSN, RNC-NIC | Clinical NICU Specialist | Medela
Target audience: Nursing and Food & Nutrition.
Continuing Education available for Nursing only.
Questions should be directed to Medela at: education@medela.com; (800) 435-8316 x2486
Course ID: 1310046W
* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.
